| Non-Hodgkin Lymphoma (NHL) |
1 |
1 |
| Diffuse Large B-Cell Lymphoma |
0 |
0.78 |
| B-Cell Lymphoma |
0 |
0.77 |
| Lymphoma |
0 |
0.61 |
| Biologic Therapy |
0 |
0.46 |
| Immunocompromise |
0 |
0.35 |
| Prostate Cancer |
0 |
0.3 |
| Rheumatoid Arthritis |
0 |
0.27 |
| Chemotherapy |
0 |
0.22 |
| Antineoplastic Drug |
0 |
0.18 |
| Arthritis |
0 |
0.17 |
| Biopsy |
0 |
0.17 |
| Cancer |
0 |
0.16 |
| Genomic Medicine |
0 |
0.16 |
| Metastasis |
0 |
0.14 |
| Epstein-Barr Virus |
0 |
0.13 |
| Lymphoproliferative Disorders |
0 |
0.13 |
| Prostate |
0 |
0.13 |
| Toxicology |
0 |
0.12 |
| Chest X-ray |
0 |
0.11 |
| Stem Cell Research and Therapy |
0 |
0.1 |
| CT Scan |
0 |
0.09 |
| Immunodeficiency |
0 |
0.09 |
| Monoclonal Antibody |
0 |
0.09 |
| Remission |
0 |
0.09 |
| Thorax |
0 |
0.09 |
| Tissue |
0 |
0.09 |
| Tumor |
0 |
0.09 |
| Pneumonia |
0 |
0.07 |